These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34265566)

  • 1. Simultaneous measurements of single gamma ray of
    Ogane K; Uenomachi M; Shimazoe K; Takahashi M; Takahashi H; Seto Y; Momose T
    Appl Radiat Isot; 2021 Oct; 176():109864. PubMed ID: 34265566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous in vivo imaging with PET and SPECT tracers using a Compton-PET hybrid camera.
    Uenomachi M; Takahashi M; Shimazoe K; Takahashi H; Kamada K; Orita T; Ogane K; Tsuji AB
    Sci Rep; 2021 Sep; 11(1):17933. PubMed ID: 34504184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compton-camera-based SPECT for thyroid cancer imaging.
    Yu H; Wang G
    J Xray Sci Technol; 2021; 29(1):111-124. PubMed ID: 33325449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent differentiated thyroid cancer: towards personalized treatment based on evaluation of tumor characteristics with PET (THYROPET Study): study protocol of a multicenter observational cohort study.
    Kist JW; de Keizer B; Stokkel MP; Hoekstra OS; Vogel WV;
    BMC Cancer; 2014 Jun; 14():405. PubMed ID: 24906384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
    Qiu ZL; Xue YL; Song HJ; Luo QY
    Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels.
    Wang W; Macapinlac H; Larson SM; Yeh SD; Akhurst T; Finn RD; Rosai J; Robbins RJ
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2291-302. PubMed ID: 10404792
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Parihar AS; Mittal BR; Kumar R; Shukla J; Bhattacharya A
    Thyroid; 2020 Apr; 30(4):557-567. PubMed ID: 31870227
    [No Abstract]   [Full Text] [Related]  

  • 8. Iodine-131 SPET/CT and 18F-FDG PET/CT for the identification and localization of mediastinal lymph node metastases from differentiated thyroid carcinoma.
    Xu YH; Shen CT; Xue YL; Qiu ZL; Luo QY
    Hell J Nucl Med; 2013; 16(3):199-203. PubMed ID: 24251307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-FDG-PET/CT in Patients Affected by Differentiated Thyroid Carcinoma with Positive Thyroglobulin Level and Negative 131I Whole Body Scan. It's Value Confirmed by a Bicentric Experience.
    Bertagna F; Albano D; Bosio G; Piccardo A; Dib B; Giubbini R
    Curr Radiopharm; 2016; 9(3):228-234. PubMed ID: 27210819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-ray imaging system with γ-ray coincidence for multiple-tracer imaging.
    Fukuchi T; Yamamoto S; Kataoka J; Kamada K; Yoshikawa A; Watanabe Y; Enomoto S
    Med Phys; 2020 Feb; 47(2):587-596. PubMed ID: 31800969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer.
    Iwata M; Kasagi K; Misaki T; Matsumoto K; Iida Y; Ishimori T; Nakamoto Y; Higashi T; Saga T; Konishi J
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):491-8. PubMed ID: 14666387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG-PET in the follow-up of thyroid cancer.
    Lind P; Kresnik E; Kumnig G; Gallowitsch HJ; Igerc I; Matschnig S; Gomez I
    Acta Med Austriaca; 2003; 30(1):17-21. PubMed ID: 12558561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorine-18 fluorodeoxyglucose positron emission tomography and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cancer.
    Dietlein M; Scheidhauer K; Voth E; Theissen P; Schicha H
    Eur J Nucl Med; 1997 Nov; 24(11):1342-8. PubMed ID: 9371865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of [18f]-fluorodeoxyglucose-avid metastatic thyroid cancer lesions to treatment with high-dose radioactive iodine.
    Wang W; Larson SM; Tuttle RM; Kalaigian H; Kolbert K; Sonenberg M; Robbins RJ
    Thyroid; 2001 Dec; 11(12):1169-75. PubMed ID: 12186505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Capabilities of MRI Versus 18F FDG PET-CT in Postoperative Patients with Thyroglobulin Positive, 131I-negative Local Recurrent or Metastatic Thyroid Cancer.
    Samanci C; Onal Y; Sager S; Asa S; Ustabasioglu FE; Alis D; Akman C; Sonmezoglu K
    Curr Med Imaging Rev; 2019; 15(10):956-964. PubMed ID: 32008523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-modal 3D imaging of radionuclides using multiple hybrid Compton cameras.
    Omata A; Masubuchi M; Koshikawa N; Kataoka J; Kato H; Toyoshima A; Teramoto T; Ooe K; Liu Y; Matsunaga K; Kamiya T; Watabe T; Shimosegawa E; Hatazawa J
    Sci Rep; 2022 Feb; 12(1):2546. PubMed ID: 35169183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging of
    Nakano T; Sakai M; Torikai K; Suzuki Y; Takeda S; Noda SE; Yamaguchi M; Nagao Y; Kikuchi M; Odaka H; Kamiya T; Kawachi N; Watanabe S; Arakawa K; Takahashi T
    Phys Med Biol; 2020 Feb; 65(5):05LT01. PubMed ID: 31323647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary role of 18F-fluorodeoxyglucose positron emission tomography and 131I scan in the follow-up of post-therapy differentiated thyroid cancer.
    Hsu CH; Liu RS; Wu CH; Chen SM; Shih LS
    J Formos Med Assoc; 2002 Jul; 101(7):459-67. PubMed ID: 12353337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Level of Agreement Between Pretherapeutic 124I PET and Intratherapeutic 131I Imaging in Detecting Iodine-Positive Thyroid Cancer Metastases.
    Ruhlmann M; Jentzen W; Ruhlmann V; Pettinato C; Rossi G; Binse I; Bockisch A; Rosenbaum-Krumme S
    J Nucl Med; 2016 Sep; 57(9):1339-42. PubMed ID: 27151981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.